Imexpharm

Imexpharm EBITDA per Share

The EBITDA per Share of Imexpharm (IMP.VN) as of Oct 26, 2026 is 3,062.78 VND. In the previous year, EBITDA per Share was 2,756.86 VND — a change of 11.10% (higher).

EBITDA per Share

3,062.78VND

YoY

11.10%

Last updated:

EBITDA per Share of Imexpharm is 2025 3,062.78 VND. EBITDA per Share of Imexpharm was 2024 2,756.86 VND. It decreases by 11.10% higher compared to the previous year.

The Imexpharm EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
2,608.83 VND
Jan 1, 2019
3,274.93 VND
Jan 1, 2020
4,090.21 VND
Jan 1, 2021
3,866.43 VND
Jan 1, 2022
4,601.45 VND
Jan 1, 2023
5,591.67 VND
Jan 1, 2024
2,756.86 VND
Jan 1, 2025
3,062.78 VND
The Imexpharm EBITDA per Share history
YEAREBITDA per ShareYoY
3,062.78VND+11.10%
2,756.86VND-50.70%
5,591.67VND+21.52%
4,601.45VND+19.01%
3,866.43VND-5.47%
4,090.21VND+24.89%
3,274.93VND+25.53%
2,608.83VND+16.08%
2,247.48VND-11.35%
2,535.25VND+13.56%
2,232.51VND-26.96%
3,056.47VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

EBITDA per Share of Imexpharm is 3,062.78 VND in 2025.

EBITDA per Share of Imexpharm changed from 2,756.86 VND to 3,062.78 VND, representing a 11.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Imexpharm since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Imexpharm

All Key Metrics — Imexpharm